Mira Pharmaceuticals Updates Corporate Address and Phone
Ticker: MIRA · Form: 8-K · Filed: Sep 10, 2024 · CIK: 1904286
| Field | Detail |
|---|---|
| Company | Mira Pharmaceuticals, Inc. (MIRA) |
| Form Type | 8-K |
| Filed Date | Sep 10, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, address-change
TL;DR
Mira Pharma moved offices, new Miami address and phone number effective Sept 10.
AI Summary
On September 10, 2024, Mira Pharmaceuticals, Inc. filed an 8-K report. The filing indicates a change in the company's principal executive offices to 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131. The company's telephone number has also been updated to (737) 289-0835.
Why It Matters
This filing signals a change in the company's operational base, which could impact logistics, investor relations, and local presence.
Risk Assessment
Risk Level: low — This is a routine administrative filing regarding corporate address and contact information, with no immediate financial or operational implications.
Key Players & Entities
- Mira Pharmaceuticals, Inc. (company) — Registrant
- September 10, 2024 (date) — Filing Date
- 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131 (address) — New Principal Executive Offices
- (737) 289-0835 (phone_number) — New Telephone Number
FAQ
What is the new principal executive office address for Mira Pharmaceuticals, Inc.?
The new principal executive office address is 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131.
What is the updated telephone number for Mira Pharmaceuticals, Inc.?
The updated telephone number for Mira Pharmaceuticals, Inc. is (737) 289-0835.
On what date did Mira Pharmaceuticals, Inc. file this 8-K report?
Mira Pharmaceuticals, Inc. filed this 8-K report on September 10, 2024.
What was Mira Pharmaceuticals, Inc.'s former company name?
Mira Pharmaceuticals, Inc.'s former company name was Mira1a Therapeutics, Inc.
When did the name change from Mira1a Therapeutics, Inc. occur?
The name change from Mira1a Therapeutics, Inc. occurred on January 12, 2022.
Filing Stats: 672 words · 3 min read · ~2 pages · Grade level 13.4 · Accepted 2024-09-10 16:01:33
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share MIRA The Nasdaq
Filing Documents
- form8-k.htm (8-K) — 38KB
- 0001493152-24-035625.txt ( ) — 212KB
- mira-20240910.xsd (EX-101.SCH) — 3KB
- mira-20240910_lab.xml (EX-101.LAB) — 33KB
- mira-20240910_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MIRA PHARMACUTICALS, INC. Dated: September 10, 2024 By: /s/ Erez Aminov Name: Erez Aminov Title: Chief Executive Officer